Eckert & Ziegler Strahlen- und Medizintechnik AG Asset Resilience Ratio
Eckert & Ziegler Strahlen- und Medizintechnik AG asset resilience ratio. Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ) has an Asset Resilience Ratio of 0.02% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Eckert & Ziegler Strahlen- und Medizinte defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Eckert & Ziegler Strahlen- und Medizintechnik AG (2013–2025)
Asset resilience ratio of Eckert & Ziegler Strahlen- und Medizintechnik AG from 2013 to 2025. This chart shows how Eckert & Ziegler Strahlen- und Medizintechnik AG's Asset Resilience Ratio has changed over time. Read Eckert & Ziegler Strahlen- und Medizinte (EUZ) financial obligations for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Eckert & Ziegler Strahlen- und Medizintechnik AG's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Eckert & Ziegler Strahlen- und Medizinte asset portfolio.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €72.00K | 0.02% |
| Total Liquid Assets | €72.00K | 0.02% |
Asset Resilience Insights
- Limited Liquidity: Eckert & Ziegler Strahlen- und Medizintechnik AG maintains only 0.02% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Eckert & Ziegler Strahlen- und Medizintechnik AG Industry Peers by Asset Resilience Ratio
Compare Eckert & Ziegler Strahlen- und Medizintechnik AG's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
T&L Co. Ltd
KQ:340570 |
Medical Devices | 26.03% |
|
Paxman AB
ST:PAX |
Medical Devices | -3.83% |
|
VIROMED MEDICAL NA O.N.
XETRA:VME |
Medical Devices | 0.03% |
|
Diagnostic Medical Systems SA
PA:ALDMS |
Medical Devices | 1.48% |
|
Pulsenmore Ltd
TA:PULS |
Medical Devices | 51.61% |
|
Geratherm Medical AG
XETRA:GME |
Medical Devices | 34.89% |
Eckert & Ziegler Strahlen- und Medizintechnik AG Asset Resilience Ratio by Year (2013–2025)
Eckert & Ziegler Strahlen- und Medizintechnik AG asset resilience ratio by year from 2013 to 2025. The table below shows the annual Asset Resilience Ratio data for Eckert & Ziegler Strahlen- und Medizintechnik AG.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.02% | €72.00K ≈ $84.18K |
€457.93 Million ≈ $535.36 Million |
-0.02pp |
| 2024-12-31 | 0.03% | €144.00K ≈ $168.35K |
€442.40 Million ≈ $517.21 Million |
-0.36pp |
| 2021-12-31 | 0.39% | €1.36 Million ≈ $1.59 Million |
€347.73 Million ≈ $406.53 Million |
+0.00pp |
| 2020-12-31 | 0.39% | €1.14 Million ≈ $1.33 Million |
€292.00 Million ≈ $341.38 Million |
+0.38pp |
| 2013-12-31 | 0.01% | €22.00K ≈ $25.72K |
€178.41 Million ≈ $208.58 Million |
-- |
About Eckert & Ziegler Strahlen- und Medizintechnik AG
Eckert & Ziegler SE manufactures and sells isotope technology components worldwide. It operates through two segments, Medical and Isotope Products. The company provides small implants for the treatment of prostate cancer seeds; and eye applicators based on ruthenium-106 and iodine-125 for the treatment of uveal melanomas; brain seed, HDR and brachytherapy; therapeutic and radiotherapy accessories… Read more